Image

Biotech's Big First Half: Web Exclusive: Wall Street

Length: [5:51]

Leff describes BIO proposals to improve capital formation for biotech and make FDA more innovation friendly. Tenthoff argues capital constraints actually are stalling innovation. Piros warns FDA's budget is not sufficient to conduct its mission.

More Videos